References and Notes
1a
Trost BM.
Science
1991,
254:
1471
1b
Trost BM.
Angew. Chem., Int. Ed. Engl.
1995,
34:
259
1c
Trost BM.
Transition Metals for Organic Synthesis
Beller M.
Bolm C.
Wiley-VCH;
Weinheim:
1998.
p.1
2a
Weber L.
Curr. Med. Chem.
2002,
9:
1241
2b
Bienayme H.
Hulme C.
Oddon G.
Schmidt P.
Chem. Eur. J.
2000,
6:
3321
2c
Zhu J.
Eur. J. Org. Chem.
2003,
1133
2d
Orru RVA.
de Greef M.
Synthesis
2003,
1471
2e
Domling A.
Ugi I.
Angew. Chem. Int. Ed.
2000,
39:
3168
2f
Lee D.
Sello JK.
Schreiber SL.
Org. Lett.
2000,
2:
709
3a
Greenlee WJ.
Siegl PKS.
Ann. Rep. Med. Chem.
1992,
27:
59
3b
Shilcrat SC.
Mokhallalati MK.
Fortunak JMD.
Pridgen LN.
J. Org. Chem.
1997,
62:
8449
3c
Rizzi JP.
Nagel AA.
Rosen T.
McLean S.
Seeger T.
J. Med. Chem.
1990,
33:
2721
3d
Shapiro G.
Gomez-Lor B.
J. Org. Chem.
1994,
59:
5524
3e
Adams JL.
Boehm JC.
Kassis S.
Gorycki PD.
Webb EF.
Hall R.
Sorenson M.
Lee JC.
Ayrton A.
Griswold DE.
Gallagher TF.
Bioorg. Med. Chem. Lett.
1998,
8:
3111
4a
Laufer S.
Wagner G.
Kotschenreuther D.
Angew. Chem. Int. Ed.
2002,
41:
2290
4b
Sarshar S.
Zhang C.
Moran EJ.
Krane S.
Rodarte JC.
Benbatoul KD.
Dixon R.
Mjalli AMM.
Bioorg. Med. Chem.
2000,
10:
2599
4c
Zhang C.
Sarshar S.
Moran EJ.
Krane S.
Rodarte JC.
Benbatoul KD.
Dixon R.
Mjalli AMM.
Bioorg. Med. Chem.
2000,
10:
2603
4d
Bilodeau MT.
Cunningham AM.
J. Org. Chem.
1998,
63:
2800
5
Lamothe M.
Lannuzel M.
Perez M.
J. Comb. Chem.
2002,
4:
73
6
Kirk-Othmer Encyclopedia of Chemical Technology
3rd ed., Vol. 12:
John Wiley and Sons;
New York:
1983.
p.692-700
7a
Faghihi K.
Mirsamie A.
Sangi R.
Eur. Polym. J.
2002,
39:
247
7b
Faghihi K.
Zamani K.
Mallakpour S.
Iranian Polym. J.
2002,
11:
339
8a For an overview on the synthesis of imidazoles, see: Ebel K. In Houben-Weyl: Methoden der Organischen Chemie, Hetarene III, 1H-Imidazole
Schaumann E.
Georg Thieme Verlag;
Stuttgart, New York:
1994.
p.1-215
For recent imidazole syntheses, see:
8b
Henkel B.
Tetrahedron Lett.
2004,
45:
2219
8c
Sezen B.
Sames D.
J. Am. Chem. Soc.
2003,
125:
5274
8d
Tan KL.
Bergman RG.
Ellmann JA.
J. Am. Chem. Soc.
2002,
124:
13964
8e
Faghihi K.
Zamani K.
Mobinikhaledi A.
Turk. J. Chem.
2004,
28:
345
8f
Mahmoodi NO.
Khodace Z.
Mendeleev Commun.
2004,
304
9a
Payne GB.
J. Am. Chem. Soc.
1959,
81:
4901
9b
Payne GB.
J. Org. Chem.
1959,
24:
2048
9c
Adams R.
Johnson JR.
Wilcox CF.
Laboratory Experiments in Organic Chemistry
5th ed.:
The Macmillan Company;
New York:
1963.
p.381
10
Bhat BA.
Dhar KL.
Puri SC.
Saxena AK.
Shanmugavel M.
Qazi GN.
Bioorg. Med. Chem. Lett.
2005,
15:
3177
11
General Procedure for Preparation for 3,5-Disubstituted Imidazolones: Typical experimental procedure for synthesis of 3,5-disubstituted imidazolones as exemplified for 2a. Guanidine hydrochloride (95.5 mg, 1 mmol) was added to a solution of 2,3-epoxydiphenyl ketone (334 mg, 1 mmol) in anhyd THF (10 mL). To this was added NaH (48 mg, 2 mmol) at r.t. After 30 min, the reaction mixture was stirred at reflux temperature for 5 h; TLC analysis indicated that the reaction was complete. The reaction mixture was filtered, solvent was removed by rotatory evaporator and the residue passed through a silica gel column (CHCl3-MeOH) afforded 2a (315 mg, 72%) as a white solid; mp 281-284 °C. 1H NMR (600 MHz, DMSO-d
6): δ = 2.97 (d, J = 13.2 Hz, 1 H), 3.11 (d, J = 13.2 Hz, 1 H), 3.57 (s, 3 H, OCH3), 3.65 (s, 6 H, 2 × OCH3), 3.72 (s, 3 H, OCH3), 6.41 (s, 2 H), 6.89 (d, J = 9.0 Hz, 2 H), 7.42 (d, J = 9.0 Hz, 2 H), 8.34 (s, 1 H). 13C NMR (125 MHz, DMSO-d
6): δ = 44.8, 55.8 56.3, 60.6, 70.6 108.2, 114.0, 127.4, 132.4, 33.8, 136.7, 152.6, 158.9, 171.2, 189.0. IR (KBr): 3346.2, 32.2, 1698.2, 1645.4, 1593.4, 1299.3, 1127.9, 828.4 cm-1. MS (ESI): m/z = 386.2 [M + H], 408.0 [M + Na]. Anal. Calcd for C20H23N3O5: C, 62.32; H, 6.01; N, 10.90. Found: C, 62.13; H, 6.15; N, 11.20.
2b: White solid; mp 298-302 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 2.99 (d, J = 13.4 Hz, 1 H), 3.21 (d, J = 13.4 Hz, 1 H), 3.67 (s, 3 H, OCH3), 3.72 (s, 3 H, OCH3), 6.73 (d, J = 8.9 Hz, 2 H), 6.9 (d, J = 8.8 Hz, 2 H), 7.03 (d, J = 9.1 Hz, 2 H), 7.41 (d, J = 8.8 Hz, 2 H), 8.20 (s, 1 H). 13C NMR (125 MHz, DMSO-d
6): δ = 42.6, 54.8, 70.5, 113.1, 125.5, 127.0, 127.9, 128.0, 131.2, 141.0, 157.9, 170.2, 187.9. IR (KBr): 3347.6, 1698.3, 1652.2, 1613.4, 1513.4, 1257.6, 1033.7, 837.6 cm-1. MS (ESI): m/z = 325.2 [M + H]. Anal. Calcd for C18H19N3O3: C, 66.45; H, 5.89; N, 12.91. Found: C, 66.71; H, 6.05; N, 12.73.
3a: White solid; mp 238-241 °C. 1H NMR (600 MHz, DMSO-d
6): δ = 2.88 (d, J = 13.5 Hz, 1 H), 3.35 (d, J = 13.5 Hz, 1 H), 3.59 (s, 3 H, OCH3), 3.69 (s, 6 H, 2 × OCH3), 3.73 (s, 3 H, OCH3), 6.48 (s, 2 H), 6.95 (d, J = 8.9 Hz, 2 H), 7.51 (d, J = 8.9 Hz, 2 H), 8.51 (s, 1 H), 10.46 (s, 1 H). 13C NMR (125 MHz, DMSO-d
6): δ = 44.9, 55.8, 56.4, 60.5, 68.6, 108.4, 114.4, 127.5, 131.1, 132.0, 137.2, 152.9, 156.8, 159.6, 176.6. IR (KBr): 3444.1, 3342.0, 1766.7, 1709.4, 1586.6, 1241.9, 1129.9, 839.2 cm-1. MS (ESI): m/z = 385 [M - H], 409.2 [M + Na]. Anal. Calcd for C20H22N2O6: C, 62.16; H, 5.73; N, 7.25. Found: C, 62.13; H, 6.14; N, 7.36.
3b: White solid; mp 204-207 °C. 1H NMR (200 MHz, DMSO-d
6): δ = 2.96 (d, J = 13.5 Hz, 1 H), 3.34 (d, J = 13.5 Hz, 1 H), 3.74 (s, 3 H, OCH3), 6.96 (d, J = 8.8 Hz, 2 H), 7.16 (m, 4 H), 7.51 (d, J = 8.8 Hz, 2 H), 8.59 (s, 1 H). 13C NMR (125 MHz, DMSO-d
6): δ = 43.0, 55.6, 70.5, 113.9, 114.6, 114.8, 127.1, 132.4, 132.5, 133.5, 158.6, 160.5, 160.6, 162.6, 170.9, 188.6. IR (KBr): 3373.9, 1757.5, 1713.4, 1608.3, 1511.7, 1403.6, 1257.7, 1225.7, 845.8 cm-1. MS (ESI): m/z = 315 [M + H]. Anal. Calcd for C17H15FN2O3: C, 64.96; H, 4.81; N, 8.91. Found: C, 65.08; H, 5.09; N, 8.97.
12a Cleeland R, Grunberg E, Leimgruber W, and Weigele M. inventors; US Patent, 4045487.
; Chem. Abstr. 1977, 87, 167872
12b
Baranes RP.
Chigbo FE.
J. Org. Chem.
1963,
28:
1644